em 523 has been researched along with devazepide in 1 studies
| Studies (em 523) | Trials (em 523) | Recent Studies (post-2010) (em 523) | Studies (devazepide) | Trials (devazepide) | Recent Studies (post-2010) (devazepide) |
|---|---|---|---|---|---|
| 26 | 1 | 0 | 780 | 5 | 42 |
| Protein | Taxonomy | em 523 (IC50) | devazepide (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.0009 | |
| Gastrin/cholecystokinin type B receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| Cholecystokinin receptor type A | Homo sapiens (human) | 0.0002 | |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.245 | |
| Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | 0.27 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, H | 1 |
1 review(s) available for em 523 and devazepide
| Article | Year |
|---|---|
[Receptor agonists and antagonists: the present and future].
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzodiazepinones; Biphenyl Compounds; Cholinergic Antagonists; Devazepide; Erythromycin; Imidazoles; Ligands; Losartan; Peptides; Receptors, Cholecystokinin; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Tetrazoles | 1993 |